Published on 1 Apr 2024 on Seeking Alpha
Sanofi and Regeneron’s Dupixent set for large gains with likely COPD approval
Dupixent from Sanofi and Regeneron Pharmaceuticals is expected to gain approval for COPD, which...
NASDAQ.REGN price evolution
NASDAQ.SNY price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free